Cita APA (7a ed.)
Campiotti, L., Suter, M. B., Guasti, L., Piazza, R., Gambacorti-Passerini, C., Grandi, A. M., & Squizzato, A. (2017). Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis. European Journal of Cancer, 77, 48-57.
Cita Chicago Style (17a ed.)
Campiotti, Leonardo, Matteo Basilio Suter, Luigina Guasti, Rocco Piazza, Carlo Gambacorti-Passerini, Anna Maria Grandi, y Alessandro Squizzato. "Imatinib Discontinuation in Chronic Myeloid Leukaemia Patients with Undetectable BCR-ABL Transcript Level: A Systematic Review and a Meta-analysis." European Journal of Cancer 77 (2017): 48-57.
Cita MLA (9a ed.)
Campiotti, Leonardo, et al. "Imatinib Discontinuation in Chronic Myeloid Leukaemia Patients with Undetectable BCR-ABL Transcript Level: A Systematic Review and a Meta-analysis." European Journal of Cancer, vol. 77, 2017, pp. 48-57.
Precaución: Estas citas no son 100% exactas.